Menu
← Oncology Approval Tracker
FDA DECISION ·
Nilotinib capsules (first generic)
nilotinib hydrochloride · Apotex
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic of the referenced nilotinib capsules. Labeled settings include newly diagnosed chronic-phase Philadelphia chromosome-positive CML in adults and children aged 1 year and older, and specified adult and pediatric chronic- or accelerated-phase disease after prior treatment resistance or intolerance.
LAMPGEN ANALYSIS
Why it matters
The capsule approval is distinct from a later nilotinib tablet formulation with different administration instructions.
What research teams should watch
Confirm capsule-specific fasting and QT precautions and distinguish pediatric prior-TKI criteria from adult prior-imatinib criteria.
PRIMARY RECORDS